Adial Pharmaceuticals Inc. (ADIL)
Market Open
12 Jun, 13:53
NASDAQ (CM) NASDAQ (CM) Primary $
2. 71
-0.27
-9.0604%
$
2.32M Market Cap
- P/E Ratio
- Div Yield
365,182 Volume
-4.8 Eps
$ 2.98
Previous Close Investors:
Want to track ADIL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Adial Pharmaceuticals Inc. (ADIL) Statistics
Valuation metrics
Market Cap 2.32M
Enterprise value -2.46M
Trailing P/E (ttm) -0.39
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 0.81
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.33
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 32.18K
Average volume (90 days) 119.09K
Price summary
52-Week low 1.31
52-Week high 19
Beta -
50-Day moving average 1.82
200-Day moving average 3.72
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 6 Feb 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.49%
Return on equity -1.63%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -5.67
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.35
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 3.18%
Book value per share (mrq) 2.71
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
